Neurotrophic keratitis is a disease characterized by decreased corneal sensitivity, which leads to impaired trophism and function. The main cause of neurotrophic keratitis is damage or disease of the trigeminal nerve, which is responsible for corneal sensitivity. In this case, not only loss of sensitivity is observed, but also a change in corneal metabolism, which can lead to various complications, including ulcers and infections. Important aspects of this disease are its pathogenesis, clinical manifestations, diagnosis and treatment, which makes understanding their significant aspects necessary for proper patient management.
History of the disease and interesting historical facts
Neurotrophic keratitis was first described in the early 20th century, when attention to the neurological aspects of eye disease increased. One of the first to systematize this condition was physician J. H. Backlund in 1946, who emphasized the role of the trigeminal nerve in maintaining normal corneal function. Since then, researchers have noted an association between trigeminal nerve injury and the development of neurotrophic keratitis. In the scientific literature, various cases of neurotrophic keratitis have been documented due to a variety of factors, such as trauma, surgery, diabetic neuropathy, and viral infections, adding to the rich historical context of this disease. Interestingly, some studies show that the level of corneal sensitivity loss may vary depending on the patient’s age and comorbidities, making neurotrophic keratitis a unique subject for clinical research.
Epidemiology
Epidemiological studies show that neurotrophic keratitis is quite rare, but its prevalence may vary depending on the population and associated factors. According to various studies, the prevalence of this condition is approximately 1-5 cases per 100,000 population. It should be noted that patients with diabetes and other neurological diseases have a significantly increased risk of developing neurotrophic keratitis. A 2018 study showed that about 15% patients with diabetic neuropathy have symptoms of neurotrophic keratitis. It is also important to consider that cases of this disease may be underestimated due to the mild severity of symptoms in the early stages, which complicates diagnosis and leads to later seeking medical care.
Genetic predisposition to this disease
To date, research has shown that genetic susceptibility to neurotrophic keratitis may be associated with changes in genes responsible for neurotrophic factors. Studies have shown that mutations in the NGF (neurotrophic growth factor) gene may contribute to the development of neurotrophic keratitis. A link has also been noted between changes in genes encoding trigeminal nerve receptors and the development of this disease. Unidentified mutations in these genes may lead to a decrease in the release of neurotrophic factors needed to maintain corneal health. Thus, the genetic basis of diseases associated with neurotrophy is becoming an important area for further medical research, which may contribute to the development of new treatments.
Risk factors for the development of this disease
There are several risk factors that contribute to the development of neurotrophic keratitis, among which the following stand out:
- Eye injuries, including surgical interventions.
- Systemic diseases such as diabetes and herpes infection.
- Pathologies of the trigeminal nerve, including its damage due to neuritis or tumors.
- Long-term use of medications that affect corneal sensitivity.
- Chemical damage such as exposure to aggressive substances.
- Individual characteristics of the body, including age and predisposition to neurological diseases.
Understanding these risk factors allows for effective identification and monitoring of patients at increased risk for developing neurotrophic keratitis.
Diagnosis of this disease
Diagnosis of neurotrophic keratitis involves evaluation of clinical symptoms, laboratory tests, and imaging studies. The main symptoms of the disease may include:
- Decreased corneal sensitivity.
- Dryness and redness of the eye.
- Blurred vision.
- Pain or discomfort in the eyes.
- Discharge from the eye.
Laboratory tests may include:
- Corneal sensitivity test using a fine needle or cotton swab.
- Conducting a test for the presence of herpes infection.
- Evaluation of tear production using the Schirmer test.
Radiological examinations such as magnetic resonance imaging (MRI) or computed tomography (CT) can be useful to evaluate the condition of the trigeminal nerve and exclude other pathologies. An important step is also differential diagnosis, which is due to the presence of similar symptoms in a number of ophthalmological and neurological diseases.
Treatment
Treatment of neurotrophic keratitis can be multifaceted and depends on the stage of the disease. General treatment includes:
- Providing protection to the cornea from injury and infection.
- Using artificial tears to lubricate the eye.
- Correction of concomitant diseases such as diabetes mellitus.
Pharmacological treatment may include:
- Use of antibacterial and antiviral agents as indicated.
- Use of corticosteroids to reduce inflammation.
- Prescription of neurotrophic agents such as tocopherol and growth factor instillations.
Surgical treatment may be required for severe complications such as corneal ulcers or perforation and may include:
- Correction of corneal damage.
- Creation of external epithelium by transplantation.
- Suturing the edges of the ulcer.
Other treatments, such as contact lenses, may also be available to help protect the cornea.
List of medications used to treat this disease
Medicines used in the treatment of neurotrophic keratitis include:
- Artificial eyes (tears).
- Antibiotics (Tobramycin, Ciprofloxacin).
- Antiviral agents (Acyclovir).
- Corticosteroids (Prednisolone).
- Neurotrophic factors (Neurostimulation with physiological solutions containing growth factors).
- Tocopherol (vitamin E).
Each medication should be prescribed taking into account the individual characteristics of the patient and his/her health condition.
Disease monitoring
Monitoring the course of neurotrophic keratitis includes regular observation of changes in symptoms, assessment of corneal sensitivity and dynamics of the eyeball condition. Control stages can be carried out every three months or less often depending on the clinical situation. The prognosis with timely treatment and adequate treatment can be favorable, but the presence of complications such as corneal ulcers or infection can significantly worsen the patient's condition. Possible complications include:
- Constant discomfort and suffering of the eyes.
- Decreased visual acuity.
- Risk of corneal infections.
- The need for surgical intervention.
Monitoring and timely intervention help to minimize risks.
Age-related features of the disease
Neurotrophic keratitis may manifest itself differently depending on the age of the patient. In the elderly, the disease is more often observed against the background of concomitant diseases such as diabetes, hypertension and neurological disorders, which increases the complexity of its diagnosis and treatment. In the younger generation, as a rule, the disease can be associated with injuries or surgical interventions. In childhood, neurotrophic keratitis is rare, but can occur as a result of genetic abnormalities or injuries. It is important to consider age aspects when diagnosing and choosing treatment, as well as monitoring the condition of patients depending on their age group.
Questions and Answers
- What are the symptoms of neurotrophic keratitis?
Answer: Symptoms typically include decreased corneal sensitivity, dry eyes, redness, discomfort, and blurred vision. - How is neurotrophic keratitis diagnosed?
Answer: Diagnosis includes evaluation of corneal sensitivity, laboratory tests, and imaging tests such as MRI or CT scan to rule out other diseases. - How is neurotrophic keratitis treated?
Answer: Treatment may include the use of artificial tears, antibacterial and antiviral agents, and in severe cases, surgery. - Are there any risk factors for developing neurotrophic keratitis?
Answer: Yes, risk factors include eye trauma, trigeminal nerve disorders, and systemic diseases such as diabetes. - What is the prognosis for neurotrophic keratitis?
Answer: The prognosis may be favorable if medical help is sought in a timely manner and adequate treatment is provided, however, the presence of complications may worsen the condition.
Thus, neurotrophic keratitis is a complex and multifaceted disease that requires a careful approach and comprehensive treatment to achieve the best results in the treatment process.
